2012
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood. 2012;119(20):4597-607.
Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney. Am J Physiol Renal Physiol. 2012;303(12):F1629-40.
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discov. 2012;2(3):236-47.
The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44(12):1321-5.
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012;149(3):656-70.
Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol. 2012;31(3):243-53.
IQSeq: integrated isoform quantification analysis based on next-generation sequencing. PLoS One. 2012;7(1):e29175.
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo. Clin Cancer Res. 2012;18(21):5911-23.
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry. J Clin Pathol. 2012;65(6):496-502.